Adenocarcinoma of the Pancreas Recruiting Phase 2 Trials for Durvalumab (DB11714)

Also known as: Pancreatic adenocarcinoma / Adenocarcinoma Pancreas / Pancreas, Adenocarcinoma / Pancreas Adenocarcinoma / Adenocarcinoma of Pancreas / Adenocarcinoma, Pancreas

IndicationStatusPhase
DBCOND0029532 (Adenocarcinoma of the Pancreas)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03490760Durvalumab and "Booster" Radiation in Metastatic Adenocarcinoma of the PancreasTreatment
NCT03851614Basket Combination Study of Inhibitors of DNA Damage Response, Angiogenesis and Programmed Death Ligand 1 in Patients With Advanced Solid TumorsTreatment